849 related articles for article (PubMed ID: 6237195)
1. Formulation and noncontraceptive uses of the new, low-dose oral contraceptive.
Batzer FR
J Reprod Med; 1984 Jul; 29(7 Suppl):503-12. PubMed ID: 6237195
[TBL] [Abstract][Full Text] [Related]
2. [Pros and cons of triphasic oral contraception].
Berdah J
Contracept Fertil Sex (Paris); 1985 Dec; 13(12):1205-10. PubMed ID: 12267512
[TBL] [Abstract][Full Text] [Related]
3. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
4. The formulation of oral contraceptives: does the amount of estrogen make any clinical difference?
Speroff L
Johns Hopkins Med J; 1982 May; 150(5):170-6. PubMed ID: 7043035
[TBL] [Abstract][Full Text] [Related]
5. [Oral contraception and its beneficial gynecological effects].
Belaisch J; Hommais-loufrani B
Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188
[TBL] [Abstract][Full Text] [Related]
6. Oral contraceptives.
Shearman RP
Aust Fam Physician; 1984 Sep; 13(9):685-91. PubMed ID: 6508652
[TBL] [Abstract][Full Text] [Related]
7. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data].
Gaspard U; Dubois M
Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606
[TBL] [Abstract][Full Text] [Related]
8. [Oral contraception: failures and risks].
Foussard-blanpin O; Paillot-renaud P; Bruneau-bigot A
Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol.
Akerlund M
Acta Obstet Gynecol Scand Suppl; 1997; 164():63-5. PubMed ID: 9225641
[TBL] [Abstract][Full Text] [Related]
10. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
11. The triphasics: insights for effective clinical use.
Youngkin EQ; Miller LG
Nurse Pract; 1987 Feb; 12(2):17-8, 23, 26-8. PubMed ID: 3822267
[TBL] [Abstract][Full Text] [Related]
12. Current perspectives on combination oral contraceptives.
Smith MA; Youngkin EQ
Clin Pharm; 1984; 3(5):485-96. PubMed ID: 6386284
[TBL] [Abstract][Full Text] [Related]
13. OC practice guidelines: minimizing side effects.
Darney PD
Int J Fertil Womens Med; 1997; Suppl 1():158-69. PubMed ID: 9168375
[TBL] [Abstract][Full Text] [Related]
14. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments].
Le Coutour X
NPN Med; 1985 Apr; 5(88):471-6. PubMed ID: 12315304
[TBL] [Abstract][Full Text] [Related]
15. Rationale for a triphasic oral contraceptive.
Pasquale SA
J Reprod Med; 1984 Jul; 29(7 Suppl):560-7. PubMed ID: 6481710
[TBL] [Abstract][Full Text] [Related]
16. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
[TBL] [Abstract][Full Text] [Related]
17. Pill formulations and their effect on lipid and carbohydrate metabolism.
Brooks PG
J Reprod Med; 1984 Jul; 29(7 Suppl):539-46. PubMed ID: 6481707
[TBL] [Abstract][Full Text] [Related]
18. [How to choose an oral contraceptive in 1984].
Rozenbaum H
Contracept Fertil Sex (Paris); 1984 Nov; 12(11):1201-6. PubMed ID: 12266609
[TBL] [Abstract][Full Text] [Related]
19. [Oral contraception: users' questions].
Prolongeau JF
Soins Gynecol Obstet Pueric Pediatr; 1993 Feb; (141):32-5. PubMed ID: 8278890
[TBL] [Abstract][Full Text] [Related]
20. Oral contraceptive agents.
Shearman RP
Med J Aust; 1986 Feb; 144(4):201-5. PubMed ID: 3945219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
